Compare UPC & HTCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UPC | HTCR |
|---|---|---|
| Founded | 1998 | 2009 |
| Country | China | Japan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8M | 4.4M |
| IPO Year | 2020 | 2022 |
| Metric | UPC | HTCR |
|---|---|---|
| Price | $5.85 | $2.59 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 791.7K | 29.1K |
| Earning Date | 01-29-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 87.84% |
| EPS Growth | N/A | ★ 414.29 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $30,407,229.00 |
| Revenue This Year | N/A | $123.26 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 39.19 |
| 52 Week Low | $2.00 | $0.15 |
| 52 Week High | $17.96 | $3.97 |
| Indicator | UPC | HTCR |
|---|---|---|
| Relative Strength Index (RSI) | 54.41 | 49.11 |
| Support Level | $2.87 | $2.50 |
| Resistance Level | $7.20 | $3.82 |
| Average True Range (ATR) | 0.97 | 0.26 |
| MACD | 0.10 | 0.04 |
| Stochastic Oscillator | 51.59 | 67.02 |
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.
HeartCore Enterprises Inc is a software development company providing solutions for digital transformation (DX). It develops, sells, and maintains CMS and CXM platforms using digital marketing technology, RPA, process mining solutions, myInvenio and Apromore, task mining solution CONTROLIO, and 3D-VR services including Matterport and VR360. The company also provides management consulting, education, services, and support to help customers succeed with the CXM Platform. It operates through two business units, the CX division for customer experience management and the DX division for digital transformation, which provides robotics process automation, process mining, and task mining. Its products include VR360, myInvenio, Apromore, and others, with maximum revenue from the United States.